MEDCast cover art

MEDCast

MEDCast

Written by: MJH Life Sciences
Listen for free

About this listen

 MEDCast is a healthcare program brought to you by HCPLive.com that features leading medical experts who discuss a range topic within a particular condition or medical disorder.© Biological Sciences Hygiene & Healthy Living Nature & Ecology Physical Illness & Disease Science
Episodes
  • 10: Clinical Approaches for Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer

    10: Clinical Approaches for Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
    May 1 2026
    This episode reviews treatment intensification in metastatic castration-sensitive prostate cancer, focusing on why ADT plus an ARPI is the current backbone of care, what barriers still limit its use, and how clinicians think about triplet therapy, de-intensification, frail patients, and emerging biomarker-driven options such as PARP inhibitors.
    Show More Show Less
    34 mins
  • 9: Indirect Trial Comparisons in Metastatic Castration-Sensitive Prostate Cancer

    9: Indirect Trial Comparisons in Metastatic Castration-Sensitive Prostate Cancer
    May 1 2026
    This episode examines how indirect trial comparisons can help guide ARPI selection in metastatic castration-sensitive prostate cancer when head-to-head studies are unavailable, while emphasizing the importance of patient-specific factors, tolerability, and clinical judgment.
    Show More Show Less
    34 mins
  • 8: Personalizing Long-Term Treatment of Metastatic Castration-Sensitive Prostate Cancer

    8: Personalizing Long-Term Treatment of Metastatic Castration-Sensitive Prostate Cancer
    May 1 2026
    This episode explores how long-term management of metastatic castration-sensitive prostate cancer is increasingly shaped by personalized treatment planning that balances disease burden, patient fitness, quality of life, and shared decision-making.
    Show More Show Less
    33 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet